Microalbuminuria: target for renoprotective therapy PRO
نویسندگان
چکیده
منابع مشابه
P14: Mitochondria as a Target for Drug Therapy in Epilepsy
لطفاً به چکیده انگلیسی مراجعه شود.
متن کاملIrbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria.
Patients 611 patients between 30 and 70 years of age who had type 2 diabetes; hypertension defined as systolic blood pressure > 135 mm Hg or diastolic blood pressure > 85 mg, or both; persistent microalbuminuria defined as an albumin excretion rate of 20 to 200 ìg/minute; and a serum creatinine concentration < 133 ìmol/l for men or < 97 ìmol/l for women. Exclusion criteria were non-diabetic kid...
متن کاملUrinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria
BACKGROUND Previously the angiotensin II receptor blocker Irbesartan has been demonstrated to reduce the risk for progression from microalbuminuria to macroalbuminuria in type 2 diabetic patients. The purpose of this study was to evaluate the effect of treatment with Irbesartan in type 2 diabetic patients with microalbuminuria on the urinary proteome. METHODS High-resolution capillary-electro...
متن کاملPrevalence of Microalbuminuria and its Correlation to Target Organ Damage
The aim of the study was to determine the prevalence and relation between urinary albumin excretion (UAE) and target organ damage (Left ventricular hypertrophy (LVH), retinopathy and stroke) in patients with essential Hypertension. We evaluated 120 patients of essential hypertension (HT), prevalence of UAE, and its correlation to target organ damage (TOD) were determined. UAE was assessed accor...
متن کاملPro-senescence therapy for hepatocellular carcinoma
(HCC) is one of the most frequent human malignancies with poor prognosis. Due to the current limitations of therapeutic options, there is a pressing need to elucidate the molecular mechanisms underlying human hepatocarcinogenesis and to identify novel targets for systemic therapy. It has recently been shown that Deleted in Liver Cancer 1 (DLC1), encoding a RhoGAP (Rho GTPase activating protein)...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International
سال: 2014
ISSN: 0085-2538
DOI: 10.1038/ki.2013.490